Where Will Cara Therapeutics (CARA) Be in 5 Years?

It’s hard to forecast exactly how a specific stock will perform over just a 12-month period, let alone over five years. This is especially true for smaller biotech stocks, where

Read more »

Why is Innovative Industrial Properties (IIPR) Trading Up 10% in the Past Week?

Innovative Industrial Properties (IIPR) has started off 2020 with another capital raise as they look to continue to grow their already impressive portfolio of cannabis-related real estate. The company announced

Read more »

Why Canopy Growth Stock Popped 11% Yesterday

After tumbling nearly 5% in Monday trading, shares of Canadian cannabis company Canopy Growth (NYSE:CGC) rebounded Tuesday, closing the day up 11%…

Read more »

Medipharm Labs Sues HEXO for Breach of Contract

A disagreement between two Canadian cannabis companies is headed to court. Medipharm Labs (OTC:MEDIF) said in a tersely worded press release Friday that one of its subsidiaries has filed a legal claim against

Read more »

Is Aurora Cannabis the Titanic of Marijuana Stocks?

Comparing any stock to a ship probably isn’t the best analogy. However, I couldn’t help thinking of the Titanic after seeing some of the headlines over the last couple of months about Aurora

Read more »

Will Cronos Group Rebound In 2020?

Cronos Group (NASDAQ:CRON) was once known as the best-performing marijuana stock of all time, and the good news for the company is that it performed better than many of its peers in 2019.

Read more »

2020 May Be the Year Cannabis Stocks Surge Like Apple

Why go for overbought FAANG stocks that have limited upside when you can buy a badly beaten cannabis industry that’s ripe for bottom-picking? After a strong start in 2019, the

Read more »

Aurora Cannabis (ACB): Love It or Leave It?

It’s one of the most controversial names in the cannabis industry. Aurora Cannabis (NYSE:ACB) definitely has its fair share of detractors. But some think that Aurora could be one of the biggest

Read more »

1 Major Problem for the Cannabis Industry

There’s a lot of controversy surrounding the effectiveness of cannabis. While many people will claim that it has helped treat conditions that no other drug could, there are also people

Read more »

Is Aurora Cannabis a Buy at Under $2?

Aurora Cannabis’ (NYSE:ACB) stock has been sinking like a stone lately. To put into perspective its massive decline: Troubled pot stock CannTrust Holdings is down 59% over the past six months. Aurora, however, has

Read more »